X
GO

Testimonies recorded below occurred during the 85th Texas Legislature Special Session.

Table of Contents

Click here to access the Advocacy in Action Archive for testimonies during the 85th Texas Legislature regular session.


Thursday, June 28, 2018

John Hawkins, senior vice president of advocacy and public policy at the Texas Hospital Association, testified on Thursday, June 28, before the Texas House Public Health Committee on population health and rural health care delivery.


Tuesday, June 26, 2018

Kathleen Berg, M.D., physician at Dell Children’s Medical Center of Central Texas and Seton HealthCare hospitals in Austin, testified before the Texas House of Representatives Select Committee on Opioids and Substance Abuse on Tuesday, June 26, 2018.


Tuesday, June 26, 2018

Celeste Johnson, vice president of nursing at Parkland Health and Hospital System in Dallas, testified before the Texas House of Representatives Select Committee on Opioids and Substance Abuse on Tuesday, June 26, 2018.


Tuesday, June 26, 2018

Ken Mitchell, M.D., senior vice president and chief medical officer of St. David’s Healthcare in Austin, testified before the Texas House of Representatives Select Committee on Opioids and Substance Abuse on Tuesday, June 26, 2018.


Tuesday, May 15, 2018

John Hawkins, senior vice president of advocacy and public policy at the Texas Hospital Association, testified in the House Select Committee on Opioids & Substance Abuse on May 15, 2018, on the state’s prescription monitoring program.


Tuesday, April 17, 2018

Matthew Feehery, senior vice president and CEO of Memorial Hermann's Prevention and Recovery Center, Houston and member of the Texas Hospital Association's Behavioral Health Council, testified Tuesday, April 17, 2018, before the Texas House of Representatives’ Select Committee on Opioids and Substance Abuse.


Wednesday, April 4, 2018

John Hawkins, senior vice president of advocacy and public policy at the Texas Hospital Association, testified on April 4, 2018, in the Texas House Appropriations’ Subcommittee on Health and Human Services (Article II) on health care reform.


Tuesday, March 27, 2018

John Hawkins, senior vice president of advocacy and public policy at the Texas Hospital Association, testified March 27 before the Texas House of Representatives’ Select Committee on Opioids and Substance Abuse on the effect of opioid use on Texas hospitals.


Thursday, March 22, 2018

Lynnette Watkins, M.D., FACHE, chief medical officer of Baptist Health Systems and group chief medical officer of San Antonio and North Texas for Tenet Healthcare, testified on the effect of opioids and substance use in Texas before the Texas Senate Health and Human Services Committee on March 22, 2018.


Wednesday, March 21, 2018

John Hawkins, senior vice president of advocacy and public policy at the Texas Hospital Association, testified March 21, 2018, in the Texas Senate Health and Human Services Committee on compliance in Medicaid managed care.


Wednesday, March 21, 2018

John Hawkins, senior vice president of advocacy and public policy at the Texas Hospital Association, testified March 21, 2018, in the Texas Senate Health and Human Services Committee on compliance on quality in Medicaid managed care.


Wednesday, March 21, 2018

John Hawkins, senior vice president of advocacy and public policy at the Texas Hospital Association, testified March 21, 2018, in the Texas Senate Health and Human Services Committee on price transparency.


Tuesday, Jan. 30, 2018

Carrie Kroll, vice president, advocacy, quality and public health at the Texas Hospital Association, testified on Tuesday, Jan. 30, 2018, before the Texas Senate Finance Committee on trauma hospital funding.


Wednesday, Nov. 1, 2017

John Hawkins, senior vice president of advocacy and public policy at the Texas Hospital Association, testified before the Texas House Committees on Human Services and Public Health in a joint hearing on Nov. 1.


Tuesday, Aug. 22, 2017

Matthew Feehery, senior vice president and CEO of Memorial Hermann's Prevention and Recovery Center, Houston and chair of the Texas Hospital Association's Behavioral Health Council, testified Tuesday, Aug. 22, 2017, before the Texas House County Affairs Committee on the national opioid epidemic and its implications for Texas.


Tuesday, July 25, 2017

John Hawkins, senior vice president, advocacy and public policy at the Texas Hospital Association, testified on July 25 before the House Appropriations Committee during the Texas Legislature Special Session on federal health care reform and the 1115 Medicaid Waiver.


Friday, July 21, 2017

Missy Atwood, J.D., principal at Germer Beaman & Brown LLC testified on July 21 against SB 11 and SB 80 in the Senate Health and Human Services Committee during the Texas Legislature Special Session.


Friday, July 21, 2017

Robert Fine, M.D., clinical director of the Office of Clinical Ethics and Palliative Care at Baylor Scott and White Health, Dallas testified on July 21 against SB 11 and SB 80 in the Senate Health and Human Services Committee during the Texas Legislature Special Session.